Back to
RA CAPITAL MANAGEMENT, L.P.
EIDXShowing 0 of 9 quarters
Position history for
RA CAPITAL MANAGEMENT, L.P.'s holdings in EIDOS THERAPEUTICS INC
No. RA Capital Management exited its EIDX (Eidos Therapeutics) position in Q4 2020. Its Q3 2020 13F listed 2,163,271 shares worth $109.3M. RA Capital Management already held EIDX in its Q4 2018 13F, the earliest on record, and held it in 8 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of EIDX: Magnetar Financial LLC, VIKING GLOBAL INVESTORS LP, GILDER GAGNON HOWE & CO LLC, BALYASNY ASSET MANAGEMENT L.P., STATE STREET CORP